Haemonetics Corporation (HAE) Q2 2013 Earnings Results

Haemonetics Corp Beats on EPS, Stock Down 0.55%

Haemonetics Corp reported better-than-expected earnings per share, which is a positive sign for the company's profitability. However, the stock declined slightly by 0.55%, indicating that investors may have been looking for more comprehensive revenue details or guidance. The management's cautious optimism suggests they are aware of market challenges but are focused on future growth strategies.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.90	N/A	+17.49%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism despite market challenges. They emphasized their commitment to innovation and customer satisfaction.

Management highlighted strong performance in key product lines.

They noted ongoing challenges in the market but expressed confidence in their strategy.

Focus will remain on innovation and customer engagement.

Haemonetics Corp Beats on EPS, Stock Down 0.55%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Beats on EPS, Stock Down 0.55%

Key numbers

Management commentary